A recent study evaluated the activation of the NF-κB pathway in microparticles isolated from patients with SLE vs healthy controls, since elevated levels of circulation microparticles (MPs) have been reported in patients with SLE. This evidence concerns the gene NFKB1 and systemic lupus erythematosus.